AI assistant
FEVERTREE DRINKS PLC Transaction in Own Shares 2026
7637_pos_2026-06-23_a510779a-c047-4891-af27-6b022bfff7a5.html
Transaction in Own Shares
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 2053J
Fevertree Drinks PLC
23 June 2026
23rd June 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 15th June to 19th June 2026.
| Date | Venue | Volume-weighted average price (p) | Aggregated volume | Lowest price per share (p) | Highest price per share (p) |
| 15/06/2026 | AIMX | 839.5000 | 20,000 | 839.5000 | 839.5000 |
| 15/06/2026 | XLON | 836.0633 | 21,500 | 831.0000 | 850.5000 |
| 16/06/2026 | AIMX | 829.5000 | 20,000 | 829.5000 | 829.5000 |
| 16/06/2026 | XLON | 831.4864 | 21,256 | 822.5000 | 843.5000 |
| 17/06/2026 | XLON | 851.3527 | 41,666 | 842.0000 | 863.0000 |
| 18/06/2026 | AIMX | 832.5000 | 15,000 | 832.5000 | 832.5000 |
| 18/06/2026 | XLON | 827.5216 | 26,322 | 812.5000 | 843.5000 |
| 19/06/2026 | AIMX | 831.5000 | 15,000 | 831.5000 | 831.5000 |
| 19/06/2026 | XLON | 825.5938 | 23,192 | 813.0000 | 846.5000 |
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/2053J_1-2026-6-22.pdf
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I [email protected] I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I [email protected] I +44 (0)770 332 9024
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSVLLBLQQLFBBX